A Review of MD STARnet’s Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017

• Published in: Journal of Child Neurology 2019-01, Vol.34 (1), p.44-53
• Main Authors: Sahay, Kashika M., Smith, Tiffany, Conway, Kristin M., Romitti, Paul A., Lamb, Molly M., Andrews, Jennifer, Pandya, Shree, Oleszek, Joyce, Cunniff, Christopher, Valdez, Rodolfo
• Format: Article
• Language: English
• ISSN: 0883-0738; 1708-8283
• DOI: 10.1177/0883073818801704

Population studies of rare disorders, such as Duchenne and Becker muscular dystrophies (dystrophinopathies), are challenging due to diagnostic delay and heterogeneity in disorder milestones. To address these challenges, the Centers for Disease Control and Prevention established the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) in 2002 in the United States. From 2002 to 2012, MD STARnet longitudinally tracked the prevalence, clinical, and health care outcomes of 1054 individuals born from 1982 to 2011 with pediatric-onset dystrophinopathy through medical record abstraction and survey data collection. This article summarizes 31 MD STARnet peer-reviewed publications. MD STARnet provided the first population-based prevalence estimates of childhood-onset dystrophinopathy in the United States. Additional publications provided insights into diagnostic delay, dystrophinopathy-specific growth charts, and health services use. Ongoing population-based surveillance continually improves our understanding of clinical and diagnostic outcomes of rare disorders.